rs3088241
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_031307.4(PUS3):āc.1380G>Cā(p.Glu460Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.498 in 1,613,484 control chromosomes in the GnomAD database, including 201,370 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_031307.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PUS3 | NM_031307.4 | c.1380G>C | p.Glu460Asp | missense_variant | 4/4 | ENST00000227474.8 | NP_112597.4 | |
HYLS1 | NM_001134793.2 | c.-26+2379C>G | intron_variant | ENST00000425380.7 | NP_001128265.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PUS3 | ENST00000227474.8 | c.1380G>C | p.Glu460Asp | missense_variant | 4/4 | 1 | NM_031307.4 | ENSP00000227474.3 | ||
HYLS1 | ENST00000425380.7 | c.-26+2379C>G | intron_variant | 3 | NM_001134793.2 | ENSP00000414884.2 |
Frequencies
GnomAD3 genomes AF: 0.469 AC: 71155AN: 151736Hom.: 16794 Cov.: 31
GnomAD3 exomes AF: 0.492 AC: 123742AN: 251382Hom.: 30695 AF XY: 0.496 AC XY: 67328AN XY: 135874
GnomAD4 exome AF: 0.502 AC: 733023AN: 1461630Hom.: 184569 Cov.: 39 AF XY: 0.502 AC XY: 365269AN XY: 727126
GnomAD4 genome AF: 0.469 AC: 71191AN: 151854Hom.: 16801 Cov.: 31 AF XY: 0.470 AC XY: 34862AN XY: 74174
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at